Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
2.550
-0.020 (-0.78%)
At close: Jan 9, 2026, 4:00 PM EST
2.570
+0.020 (0.78%)
After-hours: Jan 9, 2026, 5:50 PM EST
Spero Therapeutics Market Cap
Spero Therapeutics has a market cap or net worth of $143.67 million as of January 9, 2026. Its market cap has increased by 185.62% in one year.
Market Cap
143.67M
Enterprise Value
98.40M
1-Year Change
185.62%
Ranking
Category
Stock Price
$2.55
Market Cap Chart
Since November 2, 2017, Spero Therapeutics's market cap has decreased from $154.10M to $143.67M, a decrease of -6.77%. That is a compound annual growth rate of -0.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 143.70M | 9.44% |
| Dec 31, 2025 | 131.30M | 133.63% |
| Dec 31, 2024 | 56.20M | -27.86% |
| Dec 29, 2023 | 77.90M | -13.06% |
| Dec 30, 2022 | 89.60M | -82.69% |
| Dec 31, 2021 | 517.50M | -1.84% |
| Dec 31, 2020 | 527.20M | 186.68% |
| Dec 31, 2019 | 183.90M | 64.34% |
| Dec 31, 2018 | 111.90M | -33.71% |
| Dec 29, 2017 | 168.80M | 9.54% |
| Nov 2, 2017 | 154.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 960.36B |
| Johnson & Johnson | 493.93B |
| AbbVie | 394.48B |
| UnitedHealth Group | 314.59B |
| AstraZeneca | 297.23B |
| Novartis AG | 273.11B |
| Merck & Co. | 271.58B |
| Novo Nordisk | 254.60B |